Jump to any asset 724 assets, updated daily
As of August 11, 2026, ASTERA LABS INC (ALAB) trades at $317.23. CleaRank Financial AI rates it Hold with a fair value of $275.00, 13.3% below the current price. RSI at 50 is in neutral territory, and the price is below its 50-day average of $357.18.

ASTERA LABS INC (ALAB)

ASTERA LABS INC NASDAQ

$317.23 -16.94 (-5.07%)
At close: Aug 10, 4:00 PM EDT
AI Analyst Consensus
Hold
55 / 100

Astera Labs Inc. (ALAB) is currently trading at $317.23, below its 50-day and 20-day moving averages, indicating potential short-term weakness. The company operates in the Technology sector, specifically Semiconductors, a highly competitive and dynamic industry. Despite a remarkable revenue growth of 104.5%, the stock's valuation appears stretched with a P/E ratio of 163.81. This high valuation, coupled with significant insider selling totaling over $1.1 billion, presents a notable risk factor for investors.

The technical indicators suggest a neutral to slightly bearish short-term outlook, with the RSI at 49.54 and the MACD in negative territory. While the stock is trading above its 200-day SMA, the recent price action below shorter-term averages warrants caution. Investors should monitor upcoming earnings reports and any shifts in insider sentiment for further directional cues.

ALAB Price Analysis

Market Metrics

Open
$338.00
Day Range
$316.78 to $342.82
Prev Close
$334.17
Volume
3.31M
52-Week Range
$97.89 to $499.48
Market Cap
$55.03B

Peer Benchmarking

Valuation vs Sector (Technology)

Performance vs XLK

Sector Position Analysis
The stock's valuation metrics position it within the sector's competitive landscape, reflecting its market standing and growth trajectory relative to industry peers.

ALAB Analysis

Company's Health 3/5
AI Analyst Target +3.00% Upside
Target Price
$326.75
AI Technical Analysis Hold

Astera Labs Inc. (ALAB) is exhibiting mixed technical signals. The stock is trading below its 20-day EMA ($326.51) and 50-day SMA ($357.18), suggesting immediate resistance levels are in effect. However, it remains above its 200-day SMA ($212.70), indicating a longer-term uptrend is still intact. The RSI is neutral at 49.54, and the MACD is negative at -8.80, pointing to a lack of strong momentum in either direction currently.

The current price action below key short-term moving averages suggests a potential for further downside pressure or consolidation. Key support can be observed around the 200-day SMA, while resistance is likely to be encountered at the 20-day EMA and 50-day SMA levels. Traders should watch for a decisive break above these resistance levels or a failure to hold the 200-day SMA for directional conviction.

ProTips
  • Monitor insider transaction filings closely for any changes in selling pressure or potential insider buying activity, which could signal a shift in sentiment.
  • Given the stock is trading below its 50-day and 20-day SMAs, consider waiting for a confirmed break above these resistance levels before initiating new long positions.
  • The significant insider selling of over $1.1 billion warrants a cautious approach; ensure any position taken has a well-defined stop-loss strategy to manage potential downside risk.
Key Catalysts
Bearish Heavy Insider Selling Pressure

Insiders have sold over $1.1 billion in stock, indicating a strong bearish signal and potentially signaling a peak in valuation or lack of confidence in future growth.

Source: Insider Filings
Bullish Exceptional Revenue Growth

Astera Labs Inc. reported revenue growth of 104.5%, demonstrating strong market demand and execution in the competitive semiconductor industry.

Source: Company Financials
Neutral Trading Below Key Moving Averages

The stock's current price is below its 20-day EMA and 50-day SMA, suggesting short-term technical weakness and potential for further consolidation or decline.

Source: Technical Analysis
Neutral Above Long-Term Support

Despite short-term weakness, Astera Labs Inc. remains above its 200-day SMA, indicating that the longer-term uptrend is still technically intact.

Source: Technical Analysis
Market Outlook

The outlook for Astera Labs Inc. (ALAB) is cautiously neutral, balancing exceptional revenue growth against significant valuation and insider selling concerns. In the base case scenario, the stock may trade sideways or experience modest declines as it consolidates below key moving averages. A price target in the range of $270 to $290 could be seen if the market continues to price in growth but remains wary of the high multiple and insider activity.

Upside potential would require a significant acceleration in earnings growth or a shift in insider sentiment, potentially pushing the stock back towards its previous highs. Conversely, a failure to meet aggressive growth expectations, increased competition, or a broader market downturn could lead to a more substantial correction, with the 200-day SMA at $212.70 acting as a critical support level.

Key Statistics

Market Cap 55.03B
P/E Ratio 163.81
EPS (TTM) 2.04
Dividend Yield 0.00%
52 Week High 499.48
52 Week Low 97.89

Astera Labs Inc. (ALAB) presents a complex fundamental picture, characterized by exceptional revenue growth juxtaposed with a very high valuation. The company's P/E ratio stands at an elevated 163.81, significantly above the sector average, and its EPS is $2.04. This suggests that the market has priced in substantial future growth, making the stock sensitive to any deviations from optimistic expectations. The impressive 104.5% revenue growth is a strong positive, but investors must weigh this against the current market multiple.

The balance sheet strength and profitability metrics are not detailed in the provided data, but the high P/E ratio implies that profitability must be robust to justify such a valuation over the long term. Given the current price action and insider selling, the market may be reassessing the sustainability of this growth and the company's ability to meet lofty expectations. Further due diligence into profit margins and debt levels would be prudent.

Earnings & Growth Analysis

While specific recent earnings data (EPS beat/miss, forward guidance) is not provided, Astera Labs Inc. (ALAB) has demonstrated a strong top-line performance with a reported revenue growth of 104.5%. This indicates significant market traction and demand for its semiconductor products. The high P/E ratio of 163.81 suggests that the market anticipates continued aggressive growth in both revenue and earnings going forward.

Investors should closely monitor upcoming earnings releases for confirmation of sustained revenue expansion and the development of profitability. Any signs of slowing growth or margin compression could be amplified due to the current high valuation, making future earnings reports critical inflection points for the stock's trajectory.

Key Risks

Astera Labs Inc. (ALAB) faces significant risks, primarily stemming from its stretched valuation and substantial insider selling. The P/E ratio of 163.81 is exceptionally high, indicating that the stock is priced for perfection, leaving little room for error. Furthermore, over $1.1 billion in insider sales signals a potential lack of confidence from management regarding future stock performance or a realization of gains at peak valuation.

The competitive landscape within the semiconductor industry also poses a risk, as rapid technological advancements and intense competition can quickly impact market share and profitability. Investors should be wary of the potential for a valuation reset if growth expectations are not met or if broader market sentiment shifts away from high-growth technology stocks.

Technical Indicators i

RSI (14) 49.54
MACD -8.80
SMA 50 357.18
SMA 200 212.70
Technical Rating Bearish
RSI
Neutral
SMA Cross
Bullish
Price vs SMA
Bearish
MACD
Bearish
Golden Cross in effect with the 50-day SMA ($357.18) above the 200-day SMA ($212.70), price is trading below the 50-day SMA.

Market Correlations

How this stock moves relative to other assets

Based on 1 year of daily price data. Correlations may vary over different time periods.

S&P 500 (SPY) +0.47
Moderate correlation
Nasdaq 100 (QQQ) +0.56
Moderate correlation
Bitcoin (BTC) +0.40
Weak correlation
Gold (XAU) +0.09
Weak correlation
Check Custom Correlation

ALAB Trade Plans

Specific entry, exit, and risk management levels

Select Your Trade Bias
Risk Tolerance
Conservative 2% Aggressive
Portfolio Value
$
Position Size: Enter portfolio size →

Entry Strategies (click to switch)

CONSERVATIVE
$314.06
Slight discount to current
Wait for small dip
AGGRESSIVE
$317.23
At current price
Enter now if confident

Risk Management

STOP LOSS
$275.33
MAX LOSS
-12.3%
Volatility-Adjusted Stop Loss
Calculated based on RSI (49.5) and current market volatility

Profit Targets (Based on Conservative Entry)

TARGET 1
$323.48
+3% (Conservative)
+2.0% (Aggressive)
TARGET 2
$329.76
+5% (Conservative)
+4.0% (Aggressive)
TARGET 3
$339.18
+8% (Conservative)
+6.9% (Aggressive)
Consider scaling out: Take 50% profit at Target 1, 30% at Target 2, let 20% run to Target 3
⚠️ High-Volatility Risk Disclaimer
ALAB is classified as a high-volatility asset (Daily Vol: 7.54%). Aggressive price swings can lead to rapid capital loss. Liquidity risks may prevent exiting trades at desired prices. This AI-generated analysis is for educational purposes only and is not financial advice. Generated on August 11, 2026.

Compare Stocks

Compare stocks against top peers and benchmarks.

ALAB
317.23
-5.07%
+ Compare

Risk & Volatility i

Risk Level Very High
Daily Volatility
7.54%
30-day average
52-Week Range
$97.89 224% from low $499.48
Risk Considerations
Monitor position sizing based on current volatility levels
Consider stop-loss placement beyond recent price range
Diversification helps mitigate single-stock risk exposure

Growth of $10,000

Compare with Another Ticker

Monte Carlo Projection (10yr)

ALAB Insider Trading Analysis

Source: SEC Form 4
Bought
None
No open-market buys
Sold
$1.1B
87 Transactions
Insiders
12
Active Traders
$
Avg Transaction
$13.2M
Large trades
Date Insider Type Shares Value

Frequently Asked Questions

Astera Labs Inc. is currently trading below its key short-term moving averages, and significant insider selling has been reported. While revenue growth is strong, the high valuation and neutral technical indicators suggest a 'Hold' rating is more appropriate than a 'Buy' at this time.
The $1.1 billion in total insider sales versus $0 in purchases indicates a heavy insider selling for Astera Labs Inc. This suggests that company insiders have a bearish outlook on the stock's future performance or are taking profits at current elevated levels.
Astera Labs Inc.'s P/E ratio of 163.81 is substantially higher than the sector average of 25.5, indicating a significant valuation premium. While its revenue growth of 104.5% is exceptional, the market is pricing in considerable future expansion.
Key resistance levels for Astera Labs Inc. are its 20-day EMA at $326.51 and its 50-day SMA at $357.18. The 200-day SMA at $212.70 serves as a critical support level to monitor for longer-term trend confirmation.
The primary risk for Astera Labs Inc. is its stretched valuation. A P/E of 163.81 means the stock is highly sensitive to any disappointment in growth expectations or profitability, potentially leading to a sharp correction.
The outlook for Astera Labs Inc. is cautious. While strong revenue growth is a positive, the high valuation, below-average technicals, and heavy insider selling suggest a period of consolidation or potential pullback is more likely than significant upside in the near term.
A neutral RSI (49.5) and negative MACD (-8.80) for Astera Labs Inc. suggest a lack of strong bullish momentum. This indicates that the stock is not currently exhibiting the technical strength typically associated with a strong buying opportunity, leaning towards a neutral or slightly bearish short-term sentiment.